ACORN BIOVENTURES, L.P. 13D and 13G filings for Y-mAbs Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-03 1:46 pm Purchase |
2023-03-15 | 13G | Y-mAbs Therapeutics, Inc. YMAB |
ACORN BIOVENTURES, L.P. | 2,326,528 5.300% |
2,326,528 (New Position) |
Filing |